The UK-based pharmaceutical titan insisted its decision today was a commercial one due to demand being slim, with its jab no longer being manufactured. Read this story
The UK-based pharmaceutical titan insisted its decision today was a commercial one due to demand being slim, with its jab no longer being manufactured. Read this story
More from dailym.ai | dailymail health War Crimes Pfizer Oxford University Sweden Twitter European Union Novavax AstraZeneca Cancer Moderna BBC NHS